Heini Kallio

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer

Gillian Vandekerkhove, Werner J. Struss, Matti Annala et al. · European Urology · 2019 · 173 citations

Urology, Potential Utility, Genitourinary Cancer +10

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

Heini Kallio, Reija Hieta, Leena Latonen et al. · British Journal of Cancer · 2018 · 89 citations · Full text

The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian α-carbonic anhydrase isoforms

Seppo Parkkila, Alessio Innocenti, Heini Kallio et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 70 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +6

Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial

Matti Annala, Simon Fu, Jack V. W. Bacon et al. · Annals of Oncology · 2021 · 67 citations

Urology, Phase Ii Trial, Genitourinary Cancer +8

Expression of carbonic anhydrases IX and XII during mouse embryonic development

Heini Kallio, Silvia Pastoreková, Jaromı́r Pastorek et al. · BMC Developmental Biology · 2006 · 54 citations · Full text